These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 9990013

  • 1. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K, Komine J, Matsuo M, Seino S, Amachi T.
    Proc Natl Acad Sci U S A; 1999 Feb 16; 96(4):1268-72. PubMed ID: 9990013
    [Abstract] [Full Text] [Related]

  • 2. MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.
    Ueda K, Inagaki N, Seino S.
    J Biol Chem; 1997 Sep 12; 272(37):22983-6. PubMed ID: 9287292
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit.
    Gribble FM, Tucker SJ, Haug T, Ashcroft FM.
    Proc Natl Acad Sci U S A; 1998 Jun 09; 95(12):7185-90. PubMed ID: 9618560
    [Abstract] [Full Text] [Related]

  • 10. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
    Hambrock A, Löffler-Walz C, Quast U.
    Br J Pharmacol; 2002 Aug 09; 136(7):995-1004. PubMed ID: 12145099
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J.
    EMBO J; 1998 Oct 01; 17(19):5529-35. PubMed ID: 9755153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1.
    Matsuo M, Tucker SJ, Ashcroft FM, Amachi T, Ueda K.
    FEBS Lett; 1999 Sep 24; 458(3):292-4. PubMed ID: 10570926
    [Abstract] [Full Text] [Related]

  • 16. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U.
    J Pharmacol Exp Ther; 2007 Aug 24; 322(2):701-8. PubMed ID: 17495126
    [Abstract] [Full Text] [Related]

  • 17. ATP binding properties of the nucleotide-binding folds of SUR1.
    Matsuo M, Kioka N, Amachi T, Ueda K.
    J Biol Chem; 1999 Dec 24; 274(52):37479-82. PubMed ID: 10601323
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional clustering of mutations in the dimer interface of the nucleotide binding folds of the sulfonylurea receptor.
    Masia R, Nichols CG.
    J Biol Chem; 2008 Oct 31; 283(44):30322-9. PubMed ID: 18715873
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.